Aslan Alphan/iStock via Getty Images
Rhythm Pharmaceuticals (RYTM +12.1%) has recorded the biggest intraday gain since November 2020 after Ladenburg Thalmann upgraded the commercial-stage biopharmaceutical company to Buy from Neutral.
The firm highlighted the prospects of Imcivree, an FDA-approved therapy